Literature DB >> 21896853

Induction of retinal pigment epithelial cells from monkey iPS cells.

Satoshi Okamoto1, Masayo Takahashi.   

Abstract

PURPOSE: The induced pluripotent stem (iPS) cell is expected to be a powerful tool for research and development in regenerative medicine. Previously, the authors reported that human iPS cells differentiated into retinal cells, including photoreceptors and retinal pigment epithelial cells. In this study, they produced iPS cell lines from monkeys to investigate their ability to differentiate into retinal cells.
METHODS: To generate iPS cells, the fibroblasts derived from cynomolgus monkey abdominal skin were infected with retroviruses carrying Oct3/4, Sox2, Klf4, and c-Myc genes and then were cultured on STO feeder cells. Next, the established iPS cells were cultured with the conditioned medium of PA6 cells to induce RPE cells. The properties of the differentiated RPE cells were analyzed.
RESULTS: Approximately 1 month after viral infection, some epithelial-like colonies appeared among the fibroblasts. These colonies were morphologically similar to the cynomolgus embryonic stem (ES) cell and expressed ES cell-specific markers. By producing teratomas in SCID mice, these cells were confirmed to have the ability to differentiate into three germ layers. In addition, the RPE cells induced from the monkey iPS cells had characteristic polygonal shapes and pigments. These cells expressed RPE cell-specific markers such as RPE65, CRALBP, Bestrophin 1, and MERTK and exhibited phagocytotic function in vitro.
CONCLUSIONS: The RPE cells derived from monkey skin with iPS cell technology can be used for autologous or allogeneic transplantation to test the possibility of immune rejection and to evaluate their function in vivo with the same techniques that will be used in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896853     DOI: 10.1167/iovs.11-8129

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

1.  Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells.

Authors:  Neil C Talbot; Wendy O Sparks; Anne M Powell; Stanislaw Kahl; Thomas J Caperna
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-12-17       Impact factor: 2.416

Review 2.  Research on induced pluripotent stem cells and the application in ocular tissues.

Authors:  Xiao-Ling Guo; Jian-Su Chen
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 3.  RNA-Seq: Improving Our Understanding of Retinal Biology and Disease.

Authors:  Michael H Farkas; Elizabeth D Au; Maria E Sousa; Eric A Pierce
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

Review 4.  Mobilizing endogenous stem cells for retinal repair.

Authors:  Honghua Yu; Thi Hong Khanh Vu; Kin-Sang Cho; Chenying Guo; Dong Feng Chen
Journal:  Transl Res       Date:  2013-11-22       Impact factor: 7.012

Review 5.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

6.  Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells.

Authors:  Jennifer L Gori; Devikha Chandrasekaran; John P Kowalski; Jennifer E Adair; Brian C Beard; Sunita L D'Souza; Hans-Peter Kiem
Journal:  Blood       Date:  2012-08-16       Impact factor: 22.113

7.  Choice of Feeders Is Important When First Establishing iPSCs Derived From Primarily Cultured Human Deciduous Tooth Dental Pulp Cells.

Authors:  Issei Saitoh; Emi Inada; Yoko Iwase; Hirofumi Noguchi; Tomoya Murakami; Miki Soda; Naoko Kubota; Hiroko Hasegawa; Eri Akasaka; Yuko Matsumoto; Kyoko Oka; Youichi Yamasaki; Haruaki Hayasaki; Masahiro Sato
Journal:  Cell Med       Date:  2015-08-26

Review 8.  Retinal repair with induced pluripotent stem cells.

Authors:  Shomoukh Al-Shamekh; Jeffrey L Goldberg
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

Review 9.  Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale.

Authors:  Lynda S Wright; M Joseph Phillips; Isabel Pinilla; Derek Hei; David M Gamm
Journal:  Exp Eye Res       Date:  2014-02-16       Impact factor: 3.467

Review 10.  Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.

Authors:  Maryam Parvini; Leila Satarian; Kazem Parivar; Mohammad Javan; Mahdi Tondar; Sajjad Ahmad; Hossein Baharvand
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.